The STING Pathway Targeting Therapeutics and Technologies, 2020-2030 by Roots Analysis

In recent years, the concept of STING pathway targeting therapeutics has generated a lot of enthusiasm within the medical science community. The growing popularity of this therapeutic technique has not only garnered the interest of several medical researchers (reflected in the increasing volume of scientific literature (1,000+ articles published since 2015) on this subject), but also industry stakeholders focused on drug development (evident in the growing number of clinical trials and the grants awarded for STING focused projects in the recent past).

To order this 310+ page report, which features 170+ figures and 200+ tables, please visit this –

The USD 2.8 billion (by 2030) financial opportunity within the STING pathway targeting technologies market has been analysed across the following segments:

  • Types of Payment
  • Upfront Payments
  • Milestone Payments
  • Type of STING Modulator
  • Agonist
  • Antagonist
  • Key Therapeutic Area(s)
  • Oncological Disorders
  • Inflammatory Disorders
  • Infectious Diseases
  • Others
  • Route of Administration
  • Intratumoral
  • Intravenous
  • Oral
  • Subcutaneous
  • Others
  • Type of Molecule
  • Non-nucleotide
  • Cyclic Dinucleotide
  • Live Biotherapeutics
  • Oncolytic Peptides
  • Synthetic Peptides
  • Others
  • Key Geographical Regions
  • North America
  • Europe
  • Asia-Pacific 

The STING Pathway Targeting Therapeutics and Technologies, 2020-2030 report features the following companies, which we identified to be key players in this domain:

  • Aduro Biotech
  • Bristol Myers Squibb
  • Eisai
  • GlaxoSmithKline
  • ImmuneSensor Therapeutics
  • Merck
  • Noxopharm
  • Spring Bank Pharmaceuticals
  • Synlogic

Table of Contents

1. Preface

2. Executive Summary

3. Introduction

4. STING Pathway Targeting Therapeutics: Current Market Landscape

5. STING Pathway Targeting Technologies: Current Market landscape

6. Company Profiles

7. Academic Grant Analysis 

8. STING Related Initiatives of Big Pharmaceutical Players

9. Start-up Health Indexing

10. Publication Analysis

11. Partnerships and Collaborations

12. Funding and Investment Analysis

13. Market Sizing and Opportunity Analysis

14. Executive Insights

15. Concluding Remarks

16. Appendix 1: Tabulated Data

17. Appendix 2: List of Companies and Organizations

To purchase a copy, please visit

Other Offerings

  1. Pharmaceutical Contract Manufacturing Market (2nd Edition), 2018-2028
  2. Biopharma Contract Manufacturing Market (3rd Edition), 2019 – 2030
  3. China Pharmaceutical Contract Manufacturing Services Market, 2020-2030
  4. China Biopharmaceutical Contract Manufacturing Market, 2020 – 2030

About Roots Analysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at

Contact Information

Roots Analysis Private Limited

Gaurav Chaudhary

+1 (415) 800 3415

Facebook –

LinkedIn –

Twitter –

September 7, 2021

0 responses on "The STING Pathway Targeting Therapeutics and Technologies, 2020-2030 by Roots Analysis"

    Leave a Message

    Copyrights © 2020 Blavida.
    Skip to toolbar